MLL
CBST

Moody Lynn & Lieberson’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Moody Lynn & Lieberson’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-5,718
Closed -$576K – 213
2014
Q4 		$576K Sell
5,718
-182
-3% -$14.2K 0.08% 124
2014
Q3 		$391K Hold
5,900
– – 0.06% 127
2014
Q2 		$412K Sell
5,900
-152
-3% -$10.3K 0.06% 129
2014
Q1 		$443K Sell
6,052
-508
-8% -$37.9K 0.06% 127
2013
Q4 		$452K Buy
6,560
+322
+5% +$20.8K 0.06% 133
2013
Q3 		$396K Buy
6,238
+250
+4% +$15.1K 0.06% 130
2013
Q2 		$289K Buy
+5,988
New +$294K 0.05% 126

Moody Lynn & Lieberson's CBST Position: Q1 2015 in Review

Moody Lynn & Lieberson sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 5,718 shares — an estimated $576K sold.

Moody Lynn & Lieberson first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $576K in Q4 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • Moody Lynn & Lieberson reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Moody Lynn & Lieberson sold 5,718 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $576K.
  • Moody Lynn & Lieberson first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Moody Lynn & Lieberson's CUBIST PHARMACEUTICALS INC position peaked at $576K in Q4 2014.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Moody Lynn & Lieberson's 13F filing for Q1 2015, filed 29 Apr 2015.